People

Xavier Morge is President of Porsolt, whose appointment was announced in April2025. He brings more than thirty years of leadership in life-science contract research and drug-development organizations. Previously CEO of BIOASTER, he has experience in corporate development, mergers, acquisitions and integrating research organizations. He co-founded and chaired the French association of CROs. The current Seven2 portfolio independently confirms his Porsolt presidency; his former BIOASTER affiliation is historical.